Angiogenic Imbalance and Residual Myocardial Injury in Recovered Peripartum Cardiomyopathy Patients

Circulation: Heart Failure

Volumn 9, Issue 11, 2016, Pages

  Goland, Sorel ^a   Weinstein, Jean Marc ^c   Zalik, Adi ^a   Kuperstein, Rafael ^b   Zilberman, Liaz ^a   Shimoni, Sara ^a   Arad, Michael ^b   Ben Gal, Tuvia ^d   George, Jacob ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

Author keywords

Cardiomyopathycirculating endothelial progenitor cells; echocardiography; pregnancyvascular endothelial growth factorsVEGF receptor, FLT

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; CD34 ANTIGEN; FLT1 PROTEIN, HUMAN; KDR PROTEIN, HUMAN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; VEGFA PROTEIN, HUMAN;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; ENDOTHELIAL PROGENITOR CELL; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HUMAN; HUMAN CELL; LOW DRUG DOSE; PEAK SYSTOLIC VELOCITY; PERIPARTUM CARDIOMYOPATHY; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; PRIORITY JOURNAL; TISSUE DOPPLER IMAGING; TWO DIMENSIONAL SPECKLE TRACKING ECHOCARDIOGRAPHY; BLOOD; CARDIOMYOPATHY; CASE CONTROL STUDY; CYTOLOGY; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; METABOLISM; PERINATAL PERIOD; PREGNANCY; PREGNANCY COMPLICATION; PUERPERAL DISORDER; STRESS ECHOCARDIOGRAPHY; YOUNG ADULT;

ADULT; ANTIGENS, CD34; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, STRESS; ENDOTHELIAL PROGENITOR CELLS; FEMALE; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PUERPERAL DISORDERS; RECOVERY OF FUNCTION; STROKE VOLUME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 84995812427     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.116.003349     Document Type: Article

References (35)

1. Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol. 2011;58:659-670. doi: 10.1016/j.jacc.2011.03.047.
2. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283:1183-1188. doi: 10.1001/jama.283.9.1183.
3. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006;368:687-693. doi: 10.1016/S0140-6736(06)69253-2.
4. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007;128:589-600. doi: 10.1016/j. cell.2006.12.036.
5. Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, Koulisis N, Khankin EV, Burke SD, Tudorache I, Bauersachs J, del Monte F, Hilfiker-Kleiner D, Karumanchi SA, Arany Z. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012;485:333-338. doi: 10.1038/nature11040.
6. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123:2856-2869. doi: 10.1161/CIRCULATIONAHA.109.853127.
7. Liu LX, Arany Z. Maternal cardiac metabolism in pregnancy. Cardiovasc Res. 2014;101:545-553. doi: 10.1093/cvr/cvu009.
8. Bello NA, Arany Z. Molecular mechanisms of peripartum cardiomyopathy: A vascular/hormonal hypothesis. Trends Cardiovasc Med. 2015;25:499-504. doi: 10.1016/j.tcm.2015.01.004.
9. Geft D, Schwartzenberg S, George J. Circulating endothelial progenitor cells in cardiovascular disorders. Expert Rev Cardiovasc Ther. 2008;6:1115-1121. doi: 10.1586/14779072.6.8.1115.
10. Robb AO, Mills NL, Newby DE, Denison FC. Endothelial progenitor cells in pregnancy. Reproduction. 2007;133:1-9. doi: 10.1530/REP-06-0219.
11. Goland S, Bitar F, Modi K, Safirstein J, Ro A, Mirocha J, Khatri N, Elkayam U. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Card Fail. 2011;17:426-430. doi: 10.1016/j.cardfail.2011.01.007.
12. McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, Modi K, Alexis JD, Ramani GV, Semigran MJ, Haythe J, Markham DW, Marek J, Gorcsan J III, Wu WC, Lin Y, Halder I, Pisarcik J, Cooper LT, Fett JD; IPAC Investigators. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol. 2015;66:905-914. doi: 10.1016/j.jacc.2015.06.1309.
13. Modi KA, Illum S, Jariatul K, Caldito G, Reddy PC. Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. Am J Obstet Gynecol. 2009;201:171.e1-171.e5. doi: 10.1016/j. ajog.2009.04.037.
14. Fett JD, Sannon H, Thélisma E, Sprunger T, Suresh V. Recovery from severe heart failure following peripartum cardiomyopathy. Int J Gynaecol Obstet. 2009;104:125-127. doi: 10.1016/j.ijgo.2008.09.017.
15. Blauwet LA, Libhaber E, Forster O, Tibazarwa K, Mebazaa A, Hilfiker-Kleiner D, Sliwa K. Predictors of outcome in 176 South African patients with peripartum cardiomyopathy. Heart. 2013;99:308-313. doi: 10.1136/heartjnl-2012-302760.
16. Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J. 2006;152:509-513. doi: 10.1016/j.ahj.2006.02.008.
17. Elkayam U. Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy. J Am Coll Cardiol. 2014;64:1629-1636. doi: 10.1016/j.jacc.2014.07.961.
18. Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LS, Illum S, Hatamizadeh P, Elkayam U. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail. 2009;15:645-650. doi: 10.1016/j.cardfail.2009.03.008.
19. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233-270. doi: 10.1093/ehjci/jev014.
20. Haghikia A, Podewski E, Libhaber E, Labidi S, Fischer D, Roentgen P, Tsikas D, Jordan J, Lichtinghagen R, von Kaisenberg CS, Struman I, Bovy N, Sliwa K, Bauersachs J, Hilfiker-Kleiner D. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol. 2013;108:366. doi: 10.1007/s00395-013-0366-9.
21. Di Marco GS, Kentrup D, Reuter S, Mayer AB, Golle L, Tiemann K, Fobker M, Engelbertz C, Breithardt G, Brand E, Reinecke H, Pavenstädt H, Brand M. Soluble Flt-1 links microvascular disease with heart failure in CKD. Basic Res Cardiol. 2015;110:30. doi: 10.1007/s00395-015-0487-4.
22. Le Roux S, Pepper RJ, Dufay A, Neél M, Meffray E, Lamandé N, Rimbert M, Josien R, Hamidou M, Hourmant M, Cook HT, Charreau B, Larger E, Salama AD, Fakhouri F. Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis. J Am Soc Nephrol. 2012;23:155-164. doi: 10.1681/ASN.2010080858.
23. Tuzcu ZB, Asicioglu E, Sunbul M, Ozben B, Arikan H, Koc M. Circulating endothelial cell number and markers of endothelial dysfunction in previously preeclamptic women. Am J Obstet Gynecol. 2015;213:533.e1-533.e7. doi: 10.1016/j.ajog.2015.06.043.
24. Liu Y, Zhao Y, Yu A, Zhao B, Gao Y, Niu H. Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies. Arch Gynecol Obstet. 2015;292:507-518. doi: 10.1007/s00404-015-3671-8.
25. George J, Shmilovich H, Deutsch V, Miller H, Keren G, Roth A. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng. 2006;12:331-335. doi: 10.1089/ten.2006.12.331.
26. Penno G, Pucci L, Lucchesi D, Lencioni C, Iorio MC, Vanacore R, Storti E, Resi V, Di Cianni G, Del Prato S. Circulating endothelial progenitor cells in women with gestational alterations of glucose tolerance. Diab Vasc Dis Res. 2011;8:202-210. doi: 10.1177/1479164111408938.
27. Hubel CA, Sipos PI, Crocker IP. Endothelial progenitor cells: their potential role in pregnancy and preeclampsia. Pregnancy Hypertens. 2011;1:48-58. doi: 10.1016/j.preghy.2010.11.001.
28. Fett JD. Peripartum cardiomyopathy: challenges in diagnosis and management. Expert Rev Cardiovasc Ther. 2016;18:1-7. doi: 10.1080/14779072.2016.1199273.
29. Lampinen KH, Rönnback M, Kaaja RJ, Groop PH. Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens. 2006;24:751-756. doi: 10.1097/01.hjh.0000217859.27864.19.
30. Ommen SRNishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation. 2000;102:1788-1794. doi: 10.1161/01.CIR.102.15.1788.
31. Reisner SA, Lysyansky P, Agmon Y, Mutlak D, Lessick J, Friedman Z. Global longitudinal strain: a novel index of left ventricular systolic function. J Am Soc Echocardiogr. 2004;17:630-633. doi: 10.1016/j. echo.2004.02.011.
32. VanWagner LB, Wilcox JE, Colangelo LA, Lloyd-Jones DM, Carr JJ, Lima JA, Lewis CE, Rinella ME, Shah SJ. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology. 2015;62:773-783. doi: 10.1002/hep.27869.
33. Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63(25 pt A):2751-2768. doi: 10.1016/j.jacc.2014.01.073.
34. Karaye KM, Lindmark K, Henein M. Right ventricular systolic dysfunction and remodelling in Nigerians with peripartum cardiomyopathy: a longitudinal study. BMC Cardiovasc Disord. 2016;16:27. doi: 10.1186/s12872-016-0204-8.
35. Blauwet LA, Delgado-Montero A, Ryo K, Marek JJ, Alharethi R, Mather PJ, Modi K, Sheppard R, Thohan V, Pisarcik J, McNamara DM, Gorcsan J III; IPAC Investigators. Right ventricular function in peripartum cardiomyopathy at presentation is associated with subsequent left ventricular recovery and clinical outcomes. Circ Heart Fail. 2016;9:e002756. doi: 10.1161/CIRCHEARTFAILURE.115.002756.